Literature DB >> 9658145

Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat.

H Cheng1, J Tarnok, W P Parks.   

Abstract

For productive replication of human immunodeficiency virus type 1 (HIV-1) in host cells, the viral genome-encoded transactivator Tat and several cellular transcription factors are required for efficient viral gene transcription. However, it remains unclear how the viral genome initiates transcription before Tat is transcribed or when Tat is at suboptimal levels. Here, we utilized the human T-cell leukemia type 1 Tax protein as a molecular tool to investigate the mechanism of viral gene transcription that initiates the early phase of infection of HIV-1. Tax alone does not significantly increase the activity of HIV-1 long terminal repeat (LTR) in T lymphocytes, but it markedly enhanced the replication of an infectious HIV-1 provirus with a truncated nef gene. This enhancement is preferentially mediated by the cooperation of Tax and Tat which is dependent on TAR and duplicated kappaB cis elements of the HIV-1 LTR as well as the NF-kappaB activation domain of Tax. Furthermore, phorbol myristate acetate and membrane-targeted HIV-1 Nef also enhanced the LTR activity in the presence of Tat in the TAR- and kappaB cis element-dependent manner. These data suggest that activated NF-kappaB can functionally interact with a suboptimal amount of Tat and the HIV-1 LTR for efficient initiation of viral gene transcription.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658145      PMCID: PMC109905     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat.

Authors:  S E Tong-Starkesen; P A Luciw; B M Peterlin
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

2.  Contingent genetic regulatory events in T lymphocyte activation.

Authors:  G R Crabtree
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

3.  The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity.

Authors:  J Leonard; C Parrott; A J Buckler-White; W Turner; E K Ross; M A Martin; A B Rabson
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation.

Authors:  J A Zack; A J Cann; J P Lugo; I S Chen
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

5.  TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter.

Authors:  B Berkhout; A Gatignol; A B Rabson; K T Jeang
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

6.  HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene.

Authors:  D W Ballard; E Böhnlein; J W Lowenthal; Y Wano; B R Franza; W C Greene
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

7.  Differential regulation of human immunodeficiency viruses (HIVs): a specific regulatory element in HIV-2 responds to stimulation of the T-cell antigen receptor.

Authors:  D M Markovitz; M Hannibal; V L Perez; C Gauntt; T M Folks; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  Expression of a human placental alkaline phosphatase gene in transfected cells: use as a reporter for studies of gene expression.

Authors:  P Henthorn; P Zervos; M Raducha; H Harris; T Kadesch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

9.  Mutational analysis of human T-cell leukemia virus type I Tax: regions necessary for function determined with 47 mutant proteins.

Authors:  O J Semmes; K T Jeang
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.

Authors:  G Poli; A Kinter; J S Justement; J H Kehrl; P Bressler; S Stanley; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

View more
  8 in total

1.  Human T-cell leukemia virus type-I (HTLV-I) tax is not the only one factor to enhance human immunodeficiency virus type-I (HIV-1) infection in culture-supernatants.

Authors:  A Tempaku; Y Maeda; W Song; S Harada
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

2.  A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein.

Authors:  Shixing Tang; Sherimay Ablan; Megan Dueck; Wilfredo Ayala-López; Brenda Soto; Margaret Caplan; Kunio Nagashima; Indira K Hewlett; Eric O Freed; Judith G Levin
Journal:  Virology       Date:  2006-10-19       Impact factor: 3.616

3.  Localization of retrovirus in the central nervous system of a patient co-infected with HTLV-1 and HIV with HAM/TSP and HIV-associated dementia.

Authors:  M C Levin; M K Rosenblum; C H Fox; S Jacobson
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

4.  Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef.

Authors:  Shailendra K Saxena; Gaurav Shrivastava; Sneham Tiwari; Ml Arvinda Swamy; Madhavan Pn Nair
Journal:  Future Virol       Date:  2012-06-01       Impact factor: 1.831

5.  Upregulation of HTLV-1 and HTLV-2 expression by HIV-1 in vitro.

Authors:  Upal Roy; Scott A Simpson; Debasis Mondal; Sandra Eloby-Childress; Elsa L Winsor; Mark A Beilke
Journal:  J Med Virol       Date:  2008-03       Impact factor: 2.327

Review 6.  Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions.

Authors:  Luisa Minghetti; Sergio Visentin; Mario Patrizio; Laura Franchini; Maria Antonietta Ajmone-Cat; Giulio Levi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

7.  Actinomycin D induces high-level resistance to thymidine analogs in replication of human immunodeficiency virus type 1 by interfering with host cell thymidine kinase expression.

Authors:  Tomozumi Imamichi; Michael A Murphy; Joseph W Adelsberger; Jun Yang; Catherine M Watkins; Steve C Berg; Michael W Baseler; Richard A Lempicki; Jianhui Guo; Judith G Levin; H Clifford Lane
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

8.  Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat.

Authors:  Qinmiao Sun; Hittu Matta; Preet M Chaudhary
Journal:  Retrovirology       Date:  2005-02-15       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.